Treatment of Congestive Heart Failure with Pulmonary Hypertension

First-Line Management Approach

The European Respiratory Society recommends aggressive therapy for heart failure with reduced systolic function, including ACE inhibitors/ARBs, beta-blockers, and diuretics, to optimize management of the underlying heart failure condition, while addressing any contributing factors to pulmonary hypertension 1, 2
Repair of valvular heart disease when indicated, as recommended by the European Respiratory Society, is a key component of first-line management 2
Beta-blockers, such as carvedilol, metoprolol succinate, and bisoprolol, reduce cardiovascular events and mortality in patients with hypertension and heart disease, with a target resting heart rate between 50-60 beats per minute, as suggested by the American College of Cardiology 3

The European Respiratory Society recommends identifying and treating concomitant disorders that may contribute to PH, including COPD, sleep apnea syndrome, and pulmonary embolism, and controlling risk factors for cardiovascular diseases and features of metabolic syndrome 2, 4
Currently, there is no strong evidence supporting the use of pulmonary arterial hypertension (PAH) therapies in PH due to left heart disease, as stated by the European Respiratory Society 1, 2

Left ventricular assist device (LVAD) implantation has been shown to lower pulmonary pressures through LV unloading, as recommended by the European Respiratory Society 2
Lung transplantation should be considered soon after inadequate clinical response on maximal medical therapy, as suggested by the European Heart Society 5, 6

The American College of Cardiology recommends avoiding non-dihydropyridine calcium channel blockers (verapamil, diltiazem) due to negative inotropic effects that may worsen heart failure symptoms, and avoiding clonidine and moxonidine due to potential increased mortality in heart failure 3
Monitoring for electrolyte abnormalities, particularly with diuretic therapy, is crucial, as stated by the Journal of the American College of Cardiology 7
Target blood pressure <130/80 mmHg, with more aggressive targets (<120/80 mmHg) in selected patients, as recommended by the American College of Cardiology 3

The American College of Cardiology recommends sodium restriction, exercise training with careful monitoring, and addressing lifestyle modifications including management of dyslipidemia, diabetes mellitus, obesity, and smoking cessation 3